Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsaicin 8% for Taxane-Induced Peripheral Neuropathy
NCT07602387Recruiting
- Sponsor
- Hôpital Ambroise-Paré
- Start
- Mar 2024
- Primary completion
- Mar 2027
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of capsaicin 8% patch in chemotherapy-induced peripheral neuropathy (CIPN) (2 arms), sponsored by Hôpital Ambroise-Paré. Primary endpoint: Density of small nerve fibers at 12 months. Started Mar 2024; status: recruiting.
02
Drugs
capsaicin 8% patch
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT07602387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07602387.